Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-22-032661

Options or other derivatives

  • Director acquired 1,474 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ferrante Karen Jean Director 2022-10-03 Grant or award · Stock Option (Right to Buy) +1,474 $9.08 $13,378 1,474 D: show line 1 in the form
Loading xslF345X03/doc4.xml…